iCAD highlights scientific presentations at ECR annual meeting

iCAD will highlight scientific presentations at the European Congress of Radiology, ECR, annual meeting in Vienna, Austria, Feb 28 – March 3, 2024. The Company also announced it will highlight a new release for its AI-powered ProFound Detection solution while showcasing its full Breast Health Suite in booth X1 AI-35. Adding Artificial Intelligence Case Malignancy Scoring in a Breast Screening Program to Reduce Screen-Reading Workload: A Retrospective Study. The study is aimed to assess the integration of iCAD‘s artificial intelligence mammography case malignancy scoringinto a breast screening program to alleviate screen-reading workload without compromising accuracy. Results showed that implementing ProFound AI-CMS could substantially reduce the number of human readings and workload by 24.8% to 30.6%, with a modest improvement in recall rate and no increase in false negatives observed with 10% and 15% Case Score thresholds. Retrospective Evaluation of Interval Breast Cancer: Can the Number of Interval Carcinomas be Reduced Utilizing AI Diagnostic Software? In this study, researchers assessed whether iCAD’s ProFound AI could help reduce interval carcinomas. Expected results anticipate improved IC detection rates with the software compared to initial screening, with detection accuracy influenced by set thresholds. Adding Artificial Intelligence Case Malignancy Scoring in a Breast Screening Program to Overcome Delay in Most Probably True Positive Cases: A Retrospective Study. The retrospective study aimed to assess the efficacy of implementing iCAD’s ProFound AI case scoring strategy in a breast screening program. Results showed that reading screening exams above certain Case Score thresholds identified 61% to 89% of screen-detected cancers while requiring only 5.4% to 20% of screening exams to be read. Notably, prioritizing readings of exams with Case Scores above 40% allowed for the recall of the majority of true positive cases within a short time frame. E-Poster Presentation – Breast Arterial Calcification: A Proxy for Medium and Large Vessel Atherosclerotic Calcium. In this retrospective study, researchers investigated the correlation between breast arterial calcification as detected by ProFound AI Heart Health on screening mammograms from Solis Mammography and the extent of atherosclerotic disease observed on CT imaging within 12 months of the mammogram. Analyzing data from 1,449 women, they found that a BAC score of 3 or more was associated with a significantly higher rate of clinically significant atherosclerotic disease in large and medium vessels compared to a BAC score of less than 3. Specifically, the rate increased from 11.0% to 31.0%.